Adrenomed completes full enrollment with 300 patients in AdrenOSS-2 trial with Adrecizumab in septic shock

Biocrates Life Sciences AG and Helmholtz Zentrum München Celebrate 10 Years of Partnership in Personalized Medicine

APEIRON to present preclinical APN401 data at the 2019 ESMO Congress

Ergomed plc: Interim results for the six months ended 30 June 2019

Ergomed plc: Board Change

Apogenix AG: ESMO and Apogenix Collaborate on “Recurrent Glioblastoma Management: Challenges and Opportunities” Colloquium

Apogenix AG: Publication in Human Vaccines & Immunotherapeutics Illustrates the Advantages of Hexavalent CD40 Agonists in Targeting CD40 in Immuno-Oncology

Molecular Health to present at upcoming congresses

MagForce AG to host Lunch Symposium on Local Therapies in Malignant Gliomas during the 19th European Congress of Neurosurgery (EANS2019)

Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory